Imaging of gliomas at 1.5 and 3 Tesla - A comparative study
Lambros Tselikas1, Raphaëlle Souillard-Scemama1, Olivier Naggara1
1Neuroimaging Department, Centre Hospitalier Sainte-Anne, Paris, France (L.T., R.S.-S., O.N., C.M., J.-F.M., C.O.); Neurosurgery Department, Centre Hospitalier Sainte-Anne, Paris, France (E.D., B.D., J.P.); Neuropathology Department, Centre Hospitalier Sainte-Anne, Paris, France (P.V., F.C.); INSERM U 894 Centre Hospitalier Sainte-Anne, Paris, France (O.N., C.O.); Radiation Therapy and Physics Department, Gustave Roussy Institute, Villejuif, France (F.D.); Medical Oncology department, Gustave Roussy Institute, Villejuif, France (J.D.); Université Paris Descartes, Paris, France (O.N., P.V., F.C., J.-F.M., J.P., C.O.).
Background:
Glioma follow-up is based on MRI parameters, which are correlated with survival. Although established criteria are used to evaluate tumor response, radiological markers may be confounded by differences in instrumentation including the magnetic field strength. We assessed whether MRIs obtained at 3 Tesla (T) and 1.5T provided similar information.
Methods:
We retrospectively compared imaging features of 30 consecutive patients with WHO grades II and III gliomas who underwent MRI at 1.5T and 3T within a month of each other, without any clinical changes during the same period. We compared lesion volumes on fluid attenuation inversion recovery (FLAIR), ratio of cerebral blood volume (rCBV) on perfusion-weighted imaging, contrast-to-noise ratio (CNR) on FLAIR, and on post-gadolinium 3D T1-weighted sequences between 1.5T and 3T using intraclass correlation coefficient (ICC). Concordance between observers within and between modalities was evaluated using weighted-kappa coefficient (wκ).
Results:
The mean ± SD delay between modalities (1.5T and 3T MRI) was 8.6 ± 5.6 days. Interobserver/intraobserver concordance for lesion volume was almost perfect for 1.5T (ICC = 0.96/0.97) and 3T (ICC = 0.99/0.98). Agreement between observers for contrast enhancement was excellent at 1.5T (wκ = 0.92) and 3T (wκ = 0.92). The tumor CNR was significantly higher for FLAIR at 1.5T (P < .001), but it was higher at 3T (P = .012) for contrast enhancement. Correlations between modalities for lesion volume (ICC = 0.97) and for rCBV values (ICC = 0.92) were almost perfect.
Conclusions:
In the follow-up of WHO grades II and III gliomas, 1.5T and 3T provide similar MRI features, suggesting that monitoring could be performed on either a 1.5 or a 3T MR magnet.
Insights
Magnetic resonance imaging (MRI) at 1.5 Tesla (T) and 3T provide comparable data for tracking glioma progression. This allows for flexible monitoring of patients with WHO grades II and III gliomas, regardless of the MRI scanner strength used.
Area of Science:
- Radiology
- Neuro-oncology
- Medical Imaging
Background:
- Glioma follow-up relies on MRI parameters correlated with patient survival.
- Established criteria for tumor response evaluation may be affected by variations in MRI instrumentation, such as magnetic field strength.
- This study investigates the comparability of MRI information obtained at 3 Tesla (T) and 1.5T.
Purpose of the Study:
- To assess whether MRI scans acquired at 1.5T and 3T yield similar information for glioma follow-up.
- To compare key imaging features between 1.5T and 3T MRI in patients with gliomas.
- To determine the concordance of quantitative and qualitative MRI metrics between different magnetic field strengths.
Main Methods:
- Retrospective comparison of MRI features in 30 patients with WHO grades II and III gliomas.
- Patients underwent both 1.5T and 3T MRI within one month, with no clinical changes.
- Comparison of lesion volumes (FLAIR), ratio of cerebral blood volume (rCBV), and contrast-to-noise ratio (CNR) using intraclass correlation coefficient (ICC) and weighted-kappa (wκ).
Main Results:
- Interobserver and intraobserver concordance for lesion volume was nearly perfect for both 1.5T (ICC=0.96/0.97) and 3T (ICC=0.99/0.98).
- Agreement for contrast enhancement was excellent at both 1.5T and 3T (wκ=0.92).
- Correlations for lesion volume (ICC=0.97) and rCBV (ICC=0.92) between modalities were nearly perfect.
Conclusions:
- 1.5T and 3T MRI provide similar imaging features for monitoring WHO grades II and III gliomas.
- Glioma monitoring can be reliably performed using either 1.5T or 3T MRI scanners.
- The magnetic field strength does not significantly impact the comparability of key imaging parameters for glioma follow-up.
Related Concept Videos
Imaging Studies III: Computed Tomography
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET


